| 000 | 01616 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517172628.0 | ||
| 264 | 0 | _c20180508 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1865-8652 | ||
| 024 | 7 |
_a10.1007/s12325-017-0604-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIsmaila, Afisi S | |
| 245 | 0 | 0 |
_aOnce-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial. _h[electronic resource] |
| 260 |
_bAdvances in therapy _c09 2017 |
||
| 300 |
_a2163-2172 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xeconomics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAndrostadienes _xeconomics |
| 650 | 0 | 4 |
_aBronchodilator Agents _xeconomics |
| 650 | 0 | 4 |
_aBudesonide _xeconomics |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFormoterol Fumarate _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNebulizers and Vaporizers _xeconomics |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aBirk, Ruby | |
| 700 | 1 | _aShah, Dhvani | |
| 700 | 1 | _aZhang, Shiyuan | |
| 700 | 1 | _aBrealey, Noushin | |
| 700 | 1 | _aRisebrough, Nancy A | |
| 700 | 1 | _aTabberer, Maggie | |
| 700 | 1 | _aZhu, Chang-Qing | |
| 700 | 1 | _aLipson, David A | |
| 773 | 0 |
_tAdvances in therapy _gvol. 34 _gno. 9 _gp. 2163-2172 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12325-017-0604-x _zAvailable from publisher's website |
| 999 |
_c27531485 _d27531485 |
||